Oncocyte Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Oncocyte Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2023.
  • Oncocyte Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $67.3M, a 23.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $67.3M +$12.9M +23.7% Dec 31, 2023 10-K 2024-04-16
Q4 2022 $54.4M +$17.2M +46.4% Dec 31, 2022 10-K 2024-04-16
Q4 2021 $37.2M $0 0% Dec 31, 2021 10-K 2023-04-12
Q4 2020 $37.2M +$5.42M +17.1% Dec 31, 2020 10-K 2022-03-11
Q4 2019 $31.8M +$11.9M +59.6% Dec 31, 2019 10-K 2022-03-11
Q4 2018 $19.9M +$4.81M +31.9% Dec 31, 2018 10-K 2020-03-26
Q4 2017 $15.1M +$1.13M +8.09% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $14M +$5.08M +57.3% Dec 31, 2016 10-K 2018-04-02
Q4 2015 $8.87M Dec 31, 2015 10-K 2017-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.